Severe erythroderma as a complication of continuous epoprostenol therapy

Chest

Volumn 122, Issue 1, 2002, Pages 378-380

  Ahearn, Gregory S ^a   Selim, M Angelica ^a   Tapson, Victor F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allergic reaction; Connective tissue disease; Drug reaction; Epoprostenol; Erythroderma; Pulmonary hypertension; Skin biopsy

Indexed keywords

CEFAZOLIN; CORTICOSTEROID; DEXAMETHASONE; FEXOFENADINE; FUROSEMIDE; OXYGEN; PETROLATUM; PROSTACYCLIN; SPIRONOLACTONE; TRIAMCINALONE; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DISEASE SEVERITY; ERYTHEMA; ERYTHRODERMA; FEMALE; FEVER; FLUSHING; HUMAN; NAUSEA AND VOMITING; PRIORITY JOURNAL; PRURITUS; PULMONARY HYPERTENSION; SKIN BIOPSY;

EID: 0036302317     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.1.378     Document Type: Article

References (8)

1. Continuous intravenous prostacyclin vs conventional therapy in primary pulmonary hypertension: Results of a 12-week randomized trial in 81 patients
2. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease
3. Participation of T lymphocytes in cutaneous allergic reactions to drugs
4. Metabolites and allergic drug reactions
5. Allergic reactions to drugs: Involvement of T cells
6. T-cell-mediated. Cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction
7. Clinical manifestations of allergy and their relation to HIV infection
8. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus